NO962212L - Inflammatorisk cytokinproduksjonsinhibitor inneholdende polyprenylderivater som aktiv bestanddel - Google Patents

Inflammatorisk cytokinproduksjonsinhibitor inneholdende polyprenylderivater som aktiv bestanddel

Info

Publication number
NO962212L
NO962212L NO962212A NO962212A NO962212L NO 962212 L NO962212 L NO 962212L NO 962212 A NO962212 A NO 962212A NO 962212 A NO962212 A NO 962212A NO 962212 L NO962212 L NO 962212L
Authority
NO
Norway
Prior art keywords
cytokine production
inflammatory cytokine
production inhibitor
active ingredient
inhibitor containing
Prior art date
Application number
NO962212A
Other languages
English (en)
Norwegian (no)
Other versions
NO962212D0 (no
Inventor
Akikuni Yagita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO962212D0 publication Critical patent/NO962212D0/no
Publication of NO962212L publication Critical patent/NO962212L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO962212A 1993-12-01 1996-05-30 Inflammatorisk cytokinproduksjonsinhibitor inneholdende polyprenylderivater som aktiv bestanddel NO962212L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30075193 1993-12-01
PCT/JP1994/001971 WO1995015159A1 (fr) 1993-12-01 1994-11-22 Inhibiteur de la production de cytokines inflammatoires, contenant un derive polyprenyle comme principe actif

Publications (2)

Publication Number Publication Date
NO962212D0 NO962212D0 (no) 1996-05-30
NO962212L true NO962212L (no) 1996-07-31

Family

ID=17888662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962212A NO962212L (no) 1993-12-01 1996-05-30 Inflammatorisk cytokinproduksjonsinhibitor inneholdende polyprenylderivater som aktiv bestanddel

Country Status (13)

Country Link
US (1) US5708037A (fr)
EP (1) EP0806204A4 (fr)
KR (1) KR960706333A (fr)
CN (1) CN1142765A (fr)
AU (1) AU683112B2 (fr)
CA (1) CA2177966A1 (fr)
CZ (1) CZ282294B6 (fr)
FI (1) FI962264A7 (fr)
HU (1) HUT74983A (fr)
NO (1) NO962212L (fr)
NZ (1) NZ276178A (fr)
RU (1) RU2141318C1 (fr)
WO (1) WO1995015159A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11180873A (ja) * 1997-12-22 1999-07-06 Kaken Shoyaku Kk ＮＦ−κＢ活性阻害剤
EP1935427B1 (fr) * 2000-07-03 2018-03-07 Bristol-Myers Squibb Company Utilisations des molécules mutantes solubles CTLA4
US20040022787A1 (en) 2000-07-03 2004-02-05 Robert Cohen Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
KR100448488B1 (ko) * 2001-09-03 2004-09-13 (주)프로테옴텍 베체트병의 질병 표시인자로서의 아포리포프로테인에이-1을 이용한 진단 시스템
JP4235170B2 (ja) * 2002-05-17 2009-03-11 ジェン−プロウブ インコーポレイテッド 離脱可能なロック機構を有するサンプルキャリア
RU2251694C2 (ru) * 2003-04-30 2005-05-10 Российский НИИ геронтологии Минздрава РФ Способ дифференциальной диагностики язвенного колита и болезни крона
MD480Z5 (ro) * 2011-07-07 2012-09-30 Эльвира АНДОН Metodă de tratament al colitei ulceroase nespecifice acute
CN108358788A (zh) * 2017-02-04 2018-08-03 周厚广 有机物对映体纯oa及其在制备ⅱ型糖尿病及血管并发症药物中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192953A (en) * 1975-11-18 1980-03-11 Sankyo Company Limited Polyprenyl derivatives
US4059641A (en) * 1975-11-18 1977-11-22 Sankyo Company Limited Polyprenyl derivatives
JPS57154123A (en) * 1981-03-17 1982-09-22 Sankyo Co Ltd Remedial promotor for wound
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same

Also Published As

Publication number Publication date
CA2177966A1 (fr) 1995-06-08
EP0806204A1 (fr) 1997-11-12
CZ156696A3 (en) 1997-01-15
NO962212D0 (no) 1996-05-30
HUT74983A (en) 1997-03-28
FI962264A7 (fi) 1996-07-05
CN1142765A (zh) 1997-02-12
AU683112B2 (en) 1997-10-30
WO1995015159A1 (fr) 1995-06-08
US5708037A (en) 1998-01-13
RU2141318C1 (ru) 1999-11-20
NZ276178A (en) 1997-08-22
KR960706333A (ko) 1996-12-09
FI962264A0 (fi) 1996-05-30
CZ282294B6 (cs) 1997-06-11
AU1034695A (en) 1995-06-19
EP0806204A4 (fr) 2001-06-27

Similar Documents

Publication Publication Date Title
ATE164588T1 (de) Triterpenderivat
NO944928L (no) Fremgangsmåter for inhibering av Alzheimers sykdom
NO922940L (no) Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem
JPS5412381A (en) N-alkylpiperidine derivative
WO2002018324A3 (fr) Composes immunoregulateurs et derives et methodes therapeutiques les utilisant
ATE408593T1 (de) Pyruvatderivate
NO944919L (no) Fremgangsmåte for å inhibere atrofi av huden eller vagina
NO2017045I1 (no) Farmasøøytisk preparat inneholdende 2-(2-nitro-4-ifluormetylbenzoyl)-1,3-cykloheksandion eller et farmasøytisk godtagbart salt derav
DE69133348D1 (de) Behandlung von nicht-entzündlichen darmerkrankungen
ATE221073T1 (de) Neue iridoidderivate und neovaskularisations- inhibitoren die diese als aktviven inhaltstoff enthalten
ES480605A1 (es) Procedimiento para la obtencion de derivados o-sustituidos del (mas)-cianidanol-3.
NO962212L (no) Inflammatorisk cytokinproduksjonsinhibitor inneholdende polyprenylderivater som aktiv bestanddel
NO944914L (no) Fremgangsmåte for å inhibere autoimmunsykdommer
ES2156120T3 (es) Derivados arilamidicos.
KR950700314A (ko) 루이스형 당쇄 유도체(Lewis-type sugar chain derivative)
NO944933L (no) Fremgangsmåte for å inhibere sykdomstilstander i brystet
NO944931L (no) Anvendelse av 2-fenyl-3-aroylbenzotiofener for inhibering av tidlig seksuell modenhet
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
MX9306680A (es) Compuestos de piridil-, quinolil- y naftilmetoxifenilo que inhiben la enzima lipoxigenasa y composiciones farmaceuticas que los contienen.
EE04044B1 (et) Farmatseutilised tooted veresoonte endoteelirakkude kahjustuste tagajärjel tekkinud haiguste raviksja vältimiseks
KR890009389A (ko) 바이러스를 억제시키는 방법
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
MX9203567A (es) Derivado de monocolin, procedimiento para su preparacion y medicamento que contiene este derivado.
MX9300205A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
JPH08231396A (ja) 抗ヘリコバクター・ピロリ薬

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application